NCT07774078 Effectiveness and Utility of Telemonitoring in Improving the Glycaemic Control of Diabetes Mellitus Tunisian Patients
| NCT ID | NCT07774078 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Monastir |
| Condition | Diabete Mellitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 260 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 260 participants in total. It began in 2024-08-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to evaluate the impact of a telemonitoring system on glycemic control in patients with diabetes in Tunisia. Participants in the intervention group will receive remote diabetes management through a dedicated mobile application and web platform, while the control group will receive standard diabetes care. The primary objective is to determine the effectiveness of telemonitoring in improving glycemic control, as assessed by changes in glycated hemoglobin (HbA1c) and blood glucose levels.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of diabetes mellitus with HbA1c between 7% and 10%. * Stable antidiabetic treatment for at least 4 weeks prior to enrollment. Exclusion Criteria: * Serum creatinine \>200 µmol/L. * Acute coronary syndrome or stroke. * Dementia. * Pregnancy. * Inability to participate in or comply with the telemonitoring intervention. * Severe diabetic retinopathy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07774078 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabete Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07774078 currently recruiting?
Yes, NCT07774078 is actively recruiting participants. Contact the research team at semir.nouira@rns.tn for enrollment information.
Where is the NCT07774078 trial being conducted?
This trial is being conducted at Monastir, Tunisia.
Who is sponsoring the NCT07774078 clinical trial?
NCT07774078 is sponsored by University of Monastir. The trial plans to enroll 260 participants.